Fresenius Medical Care Partners With CCINSHAE To Extend HighVolumeHDF Access In Mexico Through Pilot Program For Uninsured Patients

Author: Benzinga Newsdesk | July 03, 2025 08:28am

• High-Volume Hemodiafiltration is used for the first time in seven out of 10 CCINSHAE centers in Mexico
• In Mexico, 240 CCINSHAE patients are now being treated; more than 410 regular patients also treated
• Fresenius Medical Care is committed to expanding HighVolumeHDF therapy to all markets where it is not already present, including the United States

BAD HOMBURG, Germany, July 3, 2025 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, will extend High-Volume Hemodiafiltration (HighVolumeHDF) access for patients in seven out of 10 centers in Mexico, by partnering with the country's Coordination of National Institutes of Health and Specialty Hospitals (CCINSHAE) to develop a pilot program that provides low-income patients without medical coverage in Mexico with access to hemodialysis therapies.  

Fresenius Medical Care Mexico and CCINSHAE signed a two-year contract to enable the installation of the Fresenius Medical Care 5008S CorDiax technology in participating renal treatment centers in CCINCSHAE Centers in Mexico City (CDMX) and its metropolitan area, for a total of 150 systems in all.

Posted In: FMS